About Cortria Corporation

About company

Cortria Corporation, a pharmaceutical company, develops medicines for the treatment of cardiovascular diseases. Its product is used for the treatment of dyslipidemia, an atherogenic disorder characterized by abnormal lipid levels in the bloodstream. The company was founded in 2005 and is based in Boston, Massachusetts. As of August 24, 2010, Cortria Corporation operates as a subsidiary of DERMENA North America Inc.